Travasol 560 mg/100mL 560 mg/100 mL Injection

Travasol 560 mg/100mL is an intravenous injection containing essential amino acids. It is designed to support nutritional needs in patients who cannot consume food orally. This product is manufactured by Baxter Healthcare Corporation in the USA.

Travasol 560 mg/100mL is used to provide essential amino acids to patients who require parenteral nutrition. It is often used in clinical settings where oral intake is not possible. The injection helps maintain nitrogen balance and supports protein synthesis, which is crucial for healing and overall health.

Travasol 560 mg/100mL may cause common effects such as mild nausea or discomfort at the injection site. Some patients might experience temporary changes in blood pressure or electrolyte levels. Always consult a healthcare provider for personalized advice.

Travasol 560 mg/100mL should be administered under medical supervision. It is important to monitor electrolyte levels and kidney function during treatment. Patients with liver or kidney conditions should use this product with caution.

Travasol 560 mg/100mL may interact with other medications, especially those affecting electrolyte balance or kidney function. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.